Introduction
Gastric cancer is the second most common cause of cancer death worldwide (Hartgrink et al., 2009) . The most important known risk factor for gastric cancer development is prior infection by Helicobacter pylori, a micro-aerophilic, flagellated gram-negative bacterium, which promotes a persistent inflammatory state in the gastric mucosa that lasts for decades. Approximately 70% of the global gastric cancer burden has been attributed to H. pylori infection (Parkin, 2006) . The consequences of H. pylori-associated gastritis include chronic oxidative stress in the gastric mucosa, cell cycle dysregulation and alterations in the normal epithelial cell populations and gastric secretory physiology (Wroblewski et al., 2010) . Prospective cohort studies and randomized control trials of H. pylori eradication indicate that H. pylori-positive individuals have a 2 to 10-fold increased risk of non-cardia gastric cancer compared with uninfected subjects, and that eradication of H. pylori can reduce this risk significantly (Forman and Burley, 2006; Fuccio et al., 2009) . H. pylori infection is necessary, but not sufficient, for gastric cancer development; additional risk factors for gastric carcinogenesis include dietary components and the host's genetic background (Fock et al., 2008 , Liu et al., 2009 .
The cyclin-dependent kinase (CDK) inhibitor p27 is an important regular of the G1 to S phase transition in normal cell cycle progression (Chu et al., 2008) . Mice lacking one or both copies of p27 display increased susceptibility to tumorigenesis (Fero et al., 1998) , including gastric carcinogenesis following experimental H. pylori infection (Kuzushita et al., 2005) . A tumor suppressor function for p27 is also supported by the frequent association of low p27 levels with high-grade tumors and poor prognosis in several types of human cancer (Chu et al., 2008) . Most, though not all, studies also describe an association with p27 loss and poor prognosis in gastric cancer (Mori et al., 1997; Yasui et al., 1997; Feakins et al., 2000; Chu et al., 2008) .
The regulation of the expression, subcellular localization and activity of p27 is complex and occurs at multiple levels, including at the levels of transcription, translation and post-translation (Chu et al., 2008) . Loss of nuclear p27 expression and/or its cytoplasmic mislocalization in tumor cells have both been reported to be associated with poor outcome in cancer of the breast (Liang et al., 2002; Shin et al., 2002; Viglietto et al., 2002) , prostate (Li et al., 2006) , ovary (Duncan et al., 2010) and in astrocytomas (Hidaka et al., 2009 ). An oncogenic role for cytoplasmic p27 is supported by evidence from a 'knock-in' mouse model in which the cyclin-CDK regulatory domain of p27 appears responsible for tumor suppressor activity and a cyclin-CDKindependent function of cytoplasmic p27 promotes tumor formation (Besson et al., 2007) . A cytoplasmic, oncogenic role of p27 may be related to its ability to promote cell motility and migration via its binding to and inhibition of RhoA, as shown in cell culture by the use of a mutant p27 that cannot bind to cyclins and CDKs (Besson et al., 2004) .
Several phosphorylation sites on p27 have been mapped as targets of a variety of cellular kinases. Some of these have been implicated in regulating the subcellular localization of p27 and modifying its function (Vervoorts and Luscher, 2008; Wander et al., 2011) . Among these, phosphorylation of threonine residues at positions 157 and 198 has been linked to cytoplasmic p27 expression in several model systems (Liang et al., 2002; Shin et al., 2002; Viglietto et al., 2002; Hong et al., 2008; Larrea et al., 2009) .
We previously reported that H. pylori infection of gastric cancer cells in vitro and in vivo is associated with p27 loss and resistance to apoptosis (Shirin et al., 2000; Eguchi et al., 2004; Kim et al., 2006) . We now provide evidence that H. pylori induce cytoplasmic p27 expression, associated with phosphorylation of p27 at T157 and T198. These post-translational p27 changes are dependent upon cellular phosphoinositide-3 kinase (PI3K) and AKT signaling pathways and upon a functional H. pylori cag pathogenicity island. These data, together with our observation of frequent cytoplasmic p27 mislocalization in primary human gastric cancer, in association with worse prognosis, supports the notion that the cytoplasmic mislocalization of p27 induced by H. pylori may represent an important mechanistic link between H. pylori infection and gastric carcinogenesis.
Results

Effects of H. pylori on the nuclear and cytoplasmic localization of p27
To investigate the effects of H. pylori infection on the subcellular localization of p27, AGS cells were cocultured with H. pylori, and protein was extracted from cytoplasmic and nuclear fractions. Western blotting of these subcellular lysates demonstrated that p27 was mainly located in the nucleus before H. pylori infection, whereas p27 was predominantly cytoplasmic after H. pylori infection (Figure 1a ). The cytoplasmic to nuclear ratio of p27 expression was increased by a mean ± s.d. of 7.7 ± 3.4 fold by H. pylori infection (P ¼ 0.01). The altered subcellular localization of p27 after the addition of H. pylori was confirmed by indirect immunofluorescence (Figure 1b ). Similar results were obtained with MKN-28 cells transfected with a wildtype YFP p27 fusion construct (data not shown).
Effects of H. pylori on the phosphorylation of p27 at T157 and T198 Because cytoplasmic localization of p27 has been linked to phosphorylation of p27 at T157 and T198 in breast cancer (Liang et al., 2002; Shin et al., 2002; Viglietto et al., 2002; Larrea et al., 2009) , we next investigated whether H. pylori could induce phosphorylation of p27 at T157 and T198 in gastric cancer cells. AGS cells were serum-starved for 24 h and then infected with H. pylori for 6 h. The phosphorylation of p27 at T157 and T198 was then evaluated by immunoblotting using phospho- (a) AGS cells were treated with H. pylori strain ATCC 49503 at a multiplicity of infection of 100:1 for 6 h, and nuclear and cytoplasmic extracts immunoblotted for p27. Lamin A and a-tubulin antibodies were used to confirm enrichment for nuclear and cytoplasmic fractions, respectively. (b) Immunofluorescent confocal micrography of p27 distribution after H. pylori infection. AGS cells were incubated with or without H. pylori strain ATCC 49503 at a multiplicity of infection of 100:1 for 10 h and then processed for indirect immunofluorescence under confocal microscopy. Endogenous p27 stains red and the nuclei were identified by 4,6-diamidino-2-phenylindole (blue) staining. Original magnification Â 600.
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H. pylori increased cytoplasmic phosphorylation of p27 at T198 by a mean of 2.7±1.1 fold (Po0.05; Figure 2a ). The phosphorylation of T198 was accompanied by phosphorylation of serine 473 of AKT, indicative of AKT activation (2.2±0.4 fold increase, Po0.05) and the cytoplasmic to nuclear ratio of total p27 increased by 6.1 ± 3.6 fold (Po0.05). Available reagents did not permit detection of endogenous cellular p27pT157. However, when AGS cells were transiently transfected with wild-type Myc-tagged p27, H. pylori infection was observed to increase exogenous p27pT157 and p27pT198 (3.3 ± 0.7 fold, Po0.05 and 2.0 ± 0.2 fold, Po0.01, respectively), an effect that was confined to the cytoplasmic p27 fraction ( Figure 2b ).
Dependence of H. pylori-induced phosphorylation of p27 at T198 and cytoplasmic localization of p27 upon the PI3K pathway To investigate the involvement of PI3K in H. pylorimediated upregulation of p27 T157 and T198 phosphorylation, AGS cells were pretreated with either AKT small interfering RNA (siRNA) targeting all three isoforms of Akt1 as well as Akt2 (or a scrambled siRNA as control), or the PI3K inhibitor LY294002 at 20 mm, and were then co-cultured with H. pylori.
Inhibiting AKT activation decreased the upregulation of H. pylori's induction of p27T198 phosphorylation, whether AKT activation was inhibited through the use of AKT siRNA (1.7 ± 0.6 fold decrease in p27T198 phosphorylation, Po0.05; Figure 3a ) or by PI3K inhibition (2.9±0.1 fold decrease in p27T198 phosphorylation, Po0.05; Figure 3b ). To determine if activation of the PI3K pathway is required for the H. pylorimediated cytoplasmic localization of p27, AGS cells transfected with a wild-type p27-YFP fusion plasmid were treated with LY294002 at 20 mm for 1 h and then infected with H. pylori for another 6 h. In uninfected controls, 19±4% of AGS cells exhibited cytoplasmic p27 staining. This increased to 48 ± 6% after H. pylori infection. However, treatment with the PI3K inhibitor LY294002 inhibited cytoplasmic expression of p27, with only 15 ± 2% of cells showing cytoplasmic p27 staining before and 18 ± 3% after H. pylori infection (Figure 3c ;Po0.01). Similar effects of LY294002 were observed on endogenous p27 expression, or with AKT inhibition by AKT siRNA (data not shown). These results suggest that the cytoplasmic localization of p27 induced by H. pylori is PI3K-dependent.
Requirement of phosphorylation of p27 at T157 and T198 for the altered subcellular distribution of p27 induced by H. pylori To determine if phosphorylation of p27 at T157 and T198 is required for H. pylori-mediated changes in the subcellular localization of p27, we transfected AGS cells with either a wild-type p27-YFP fusion construct or a series of YFP-p27 mutants generated by site-directed mutagenesis. In these mutants, T157 of p27 was substituted by either non-phosphorylated alanine (p27T157A) or the phosphomimetic aspartic acid (p27T157D), T198 of p27 was replaced with either alanine (p27T198A) or aspartic acid (p27T198D), and T157 and T198 of p27 were both mutated to alanine in a double mutant (p27T157AT198A). Following transfection, p27 localization in AGS cells after H. pylori infection was investigated by confocal immunofluorescent microscopy. Following H. pylori infection, wild-type p27 was predominantly expressed in the cytoplasm, as it was with the phosphomimetic mutants YFPp27T157D and YFPp27T198D (even in the absence of H. pylori). In contrast, the p27 mutants lacking threonine phosphorylation sites at 157 and 198 (YFPp27T157A, YFPp27T198A and YFPp27T157AT198A) localized exclusively to the nucleus (Figure 4 ), thus indicating that phosphorylation of p27 at T157 and T198 are necessary for the cytoplasmic accumulation of p27 following H. pylori infection.
Dependence of specific H. pylori genes on the induction of p27 phosphorylation and AKT activation To evaluate the role of specific H. pylori factors in the induction of p27 and AKT phosphorylation, wild-type H. pylori strain 60190 or its isogenic mutants lacking the cagA, cagE, cagL or VacA genes were cocultured with AGS cells. The wild-type strain and the VacA knockout strain strongly induced the phosphorylation of endogenous AKT at Ser 437 (2.3±0.8 fold, Po0.05, and 2.8 ± 1.4 fold, Po0.05, respectively) and of p27 at T198 (3.4 ± 0.7 fold, Po0.01, and 4.7 ± 1.7 fold, Po0.01, respectively). In comparison, mutants lacking the cagA, cagE or cagL gene had much less effect on p27T198 phosphorylation, which were not significantly different to uninfected control cells. Similar results were obtained with wild-type H. pylori strain 11637 and its isogenic mutants. These results suggest that structural integrity of H. pylori's type 4 secretory system is necessary for the induction of p27 phosphorylation and activation of AKT ( Figure 5 ).
Nuclear and cytoplasmic localization of p27 in human gastric cancer and association with clinical outcome p27 expression and subcellular localization were investigated by immunohistochemical staining of human gastric tissue. The normal (non-neoplastic) stomach mucosa and the intestinal metaplastic epithelium showed uniformly strong nuclear and very weak cytoplasmic p27 expression limited to the epithelial cells lining the lower third of glands. In contrast, 81 of 164 cases (49%) of gastric cancer had low nuclear p27 expression and 67 of 164 cases (41%) had moderate to strong cytoplasmic p27 expression. Examples of the patterns and range of p27 expression in normal gastric mucosa and gastric cancer are depicted in Figures 6a-c.
No significant differences in cytoplasmic or nuclear p27 expression were observed between gastric cancers of the intestinal and diffuse histological subtypes. Regression tree analysis defined nuclear and cytoplasmic cut-off values with which to separate the four patterns of p27 expression queried in survival modeling: high -nuclear, low-cytoplasmic expression (40 cases); high-nuclear, high-cytoplasmic (43 cases); low-nuclear, low-cytoplasmic (57 cases) and low-nuclear, high-cytoplasmic expression (24 cases). The Kaplan-Meier curves show the influence of p27 localization on patient survival from gastric cancer (Figure 6d ). Overall, those gastric cancers with high cytoplasmic p27 expression are associated with a poorer prognosis than those cases with low cytoplasmic p27 expression. The very best survival was seen in cases with high-nuclear, but low-cytoplasmic p27 expression (similar to the subcellular expression of p27 of non-neoplastic gastric tissues), and the group with the worst survival had low nuclear with high cytoplasmic p27 expression. For each nuclear subclassification group (high nuclear or low nuclear expression), the presence of cytoplasmic mislocalization was associated with poorer prognosis.
In the multivariate Cox proportional hazards model, p27 expression pattern and tumor stage were statistically significant independent factors associated with survival. The estimated hazard ratios and their 95% confidence intervals are listed in Table 1 . In particular, the estimated hazard ratio for cancerassociated mortality from the Cox model is 2.8 (P ¼ 0.030) for low-nuclear, high-cytoplasmic expression versus the 'normal' high-nuclear low-cytoplasmic group, and 2.6 (P ¼ 0.016) for low-nuclear, low-cytoplasmic expression versus the 'normal' high-nuclear low-cytoplasmic expression tumors. The hazard ratio is 3.8 (Po0.0001) between stage 3-4 versus stage 1-2 tumors. Patient age, gender, tumor subtype (intestinal versus diffuse) and whether or not the patient received adjunctive chemotherapy or radiation therapy were not independent prognostic variables. Taken together, these data indicate that both low nuclear p27 and high cytoplasmic p27 expression are associated with poor survival in gastric carcinoma.
Discussion
Chronic gastritis induced by H. pylori infection is well established as an etiologic factor underlying gastric cancer, (Forman and Burley, 2006; Parkin, 2006; Wroblewski et al., 2010) , but the molecular mechanisms whereby this bacterium facilitates neoplastic transformation have not been not fully elucidated. Our results demonstrate that infection of gastric cancer cells with H. pylori leads to phosphorylation of p27 at T157 and T198, resulting in the mislocalization of p27 into the cytoplasm. Cytoplasm p27 accumulation was also observed in a majority of primary human gastric cancer specimens assayed. Our findings suggest that these post-translational effects of H. pylori on p27 may be of pathogenic significance in gastric carcinogenesis. Figure 5 Effects of H. pylori factors on phosphorylation of p27 and activation of AKT. Wild-type (WT) or isogenic mutant strains of H.pylori lacking specific genes as shown (cagA, cagE, cagL or VacA) were co-cultured with AGS cells for 6 h, and specific proteins and phosphoproteins assayed by immunoblot.
H. pylori and cytoplasmic p27 S Wen et al Cytoplasmic p27 localization has been reported in several tumor types, in association with a particularly poor prognosis (Liang et al., 2002; Shin et al., 2002; Viglietto et al., 2002; Li et al., 2006; Hidaka et al., 2009; Duncan et al., 2010) and reviewed in Chu et al. (2008) . Although the canonical role of p27 is as a tumor suppressor, interacting with nuclear CDKs (especially CDK2) to inhibit cell cycle progression and tumorigenesis (Chu et al., 2008) , recent work indicates that this tumor suppressor can have a pro-oncogenic role when mislocalized to the cytoplasm. However, an oncogenic function for cytoplasmic p27 has been suggested, based on the demonstration that cytoplasmic p27 interacts with RhoA to alter cytoskeletal function and increase cell migration (Besson et al., 2004) . Moreover, a genetic model in which p27, deficient in cyclin CDK-binding (p27CK-), was knocked in to a p27 null strain indicates that cytoplasmic p27 may be pro-oncogenic (Besson et al., 2007) . In this p27 CK knock-in (p27 CK-) mouse, four amino-acid substitutions were created in the CDKN1B gene, such that the resultant mutant p27 protein cannot bind to cyclins or CDKs, but its other functions are preserved. The p27 CK-mouse developed tumors in multiple organs.
Certain prokaryotes have devised mechanisms to modulate and dysregulate the cell cycle of the host cells with which they are in contact. Examples include the cyclomodulin family of proteins that have acetyltransferase and protease activities (Jubelin et al., 2009 ). These proteins are translocated inside eukaryotic host cells by diverse bacterial species to induce cell cycle arrest and CDK accumulation. In the case of H. pylori, Cag A, a putative oncoprotein, is translocated by the type IV secretion system inside gastric epithelial cells where it may be tyrosine phosphorylated by host cell kinases, and then activate multiple signal transduction pathways, eventuating in cell cycle dysregulation and apoptosis (Mimuro et al., 2007; Saito et al., 2010) . Our results show cag-dependent effects on the PI3K/ AKT pathway, thus confirming the results of others (Nagy et al., 2009; Tabassam et al., 2009 ). In addition, we demonstrate that p27 is consequently phosphory- Several groups have demonstrated that p27 is phosphorylated on T157 and T198 by different effectors of PI3K pathway activation, including AKT, SKG and RSK1, and these lead to cytoplasmic mislocalization of the protein (Chu et al., 2008) . It has recently been established that the phosphorylation of p27 at T198 not only stabilizes p27 (Kossatz et al., 2006; Liang et al., 2007) , but also promotes its binding to RhoA, leading to loss of actin filament stability and a p27-dependent increase in cell motility (Larrea et al., 2009) . Whereas there have been no prior reports of cytoplasmic mislocalization of p27 and phosphorylation of p27 at T157 and T198 following experimental exposure of cells to chemical carcinogens in vitro, the present study shows that an etiologic agent, H. pylori, linked to chronic gastritis and ultimately to gastric carcinoma, activates the PI3K/AKT pathway, leading to increased phosphorylations at T157 and T198, and mislocalization of p27 to the cytoplasm. AKT-mediated phosphorylation of T157, which is located within p27's nuclear localization sequence, has previously been shown to impair p27 nuclear import (Liang et al., 2002) ; an effect that has been ascribed to interference by T157 phosphorylation with the physical interaction between p27 and the importin-a carrier protein (Shin et al., 2005) . These events have been shown to mediate increased cell motility and invasion, to promote cyclin D-CDk4 assembly and, by reducing p27 access to nuclear CDks, activate the cyclin-Cdk2 complexes that drive G1-to-S phase progression.
The functional consequences of H. pylori-induced p27 phosphorylation at T157 and T198 remain to be fully elucidated. In some studies, the phosphorylation of T198 has been linked to the promotion of cell migration (Larrea et al., 2009; Schiappacassi et al., 2011) and invasion (Wu et al., 2006) , and indeed tumor metastasis (Denicourt et al., 2007) and cytoplasmic p27 following serine 10 phosphorylation has been implicated in the regulation of apoptosis (Kajihara et al., 2010) . Evaluating the expression of p27 in a large series of gastric cancer resections indicates that cytoplasmic p27 mislocalization is common in gastric cancer and that cytoplasmic p27 expression is an independent marker of poor prognosis in patients following resective gastric surgery, consistent with observations in some other tumor types (Liang et al., 2002; Shin et al., 2002; Viglietto et al., 2002; Li et al., 2006; Hidaka et al., 2009; Duncan et al., 2010) . Interestingly, the association of cytoplasmic p27 expression with adverse outcome was evident for tumors expressing 'normal' (high) nuclear expression and for tumors that had lost nuclear p27 expression. These results suggest that cytoplasmic p27 expression promotes a more aggressive gastric cancer phenotype in vivo, and imply that consideration of cytoplasmic p27 status might be of clinical utility, for example in choosing to select adjuvant therapy following potentially curative surgery in this disease.
In conclusion, cag-dependent activation of the PI3K/ AKT pathway is implicated in phosphorylation of p27 at T157 and T198 by H. pylori, causing cytoplasmic p27 mislocalization in gastric cancer cells. This is of pathophysiological importance and clinical relevance given the important role of H. pylori in the development of gastric cancer, the frequent occurrence of cytoplasmic p27 expression in gastric cancer, and the association of cytoplasmic p27 expression with adverse clinical outcome. Further studies are needed to define how the mislocalization of p27 into the cytoplasm by H. pylori promotes oncogenic cellular behavior in gastric cancer.
Materials and methods
Cell lines and reagents
Human gastric epithelial lines used were: AGS (CRL-1739) from American Type Culture Collection (Manassas, VA, USA), and MKN-28 (JCRB0253) and , both from Japan Health Sciences Foundation, Tokyo, Japan. Cells were maintained in Ham's F12 medium (AGS) or RPMI 1640 (MKN-28 and MKN-45) from Lonza Biologics Inc., Hopkinton, MA, USA) with 10% fetal bovine serum (Sigma, St. Louis, MO, USA) in 5% CO 2 at 37 1C. LY294002 (Cell Signaling Technology, Beverly, MA, USA) was used at 20 mM.
H. pylori strains and culture conditions
Wild-type H. pylori strain 60190 (ATCC #49503) was from American Type Culture Collection and its isogenic cagA, cagE, cagL and VacA negative mutants were provided by Richard Peek (Vanderbilt University, Nashville, TN, USA). Strain NCTC11639 and its isogenic cagE, PAI and OipA negative mutants were provided by Yoshio Yamaoka (Baylor College of Medicine, Houston, TX, USA). H. pylori was grown on trypticase soy agar with 5% sheep blood cells (BD Biosciences, San Jose, CA, USA) at 37 1C in 5% CO 2 , as described previously (Shirin et al., 1999) . H. pylori were added to gastric cells that had been serum-starved for 16 h and co-cultured at a ratio of 100:1 unless otherwise stated.
Protein extraction and western blot analysis Cells were harvested, washed twice with cold phosphatebuffered saline, and centrifuged. The cell pellet was lysed in NP40 cell lysis buffer (Invitrogen, Carlsbad, CA, USA) for 30 min on ice, vortexing every 10 min. After centrifugation at 13 000 r.p.m. for 10 min, the supernatant was saved for immunoblotting. For subcellular fractionation, nuclear and cytoplasmic extracts were separated using the NE-PER Nuclear and Cytoplasmic Extraction Kit (Thermo Scientific, Waltham, MA, USA) according to manufacturer's instructions. All buffers included 1 Â protease and phosphatase inhibitor cocktail (Thermo Fisher Scientific). Protein concentrations were determined using the BCA Protein Assay (Thermo Scientific). For western blotting, 20 mg protein samples were separated on SDS-polyacrylamide gel electrophoresis and transferred to a polyscreen polyvinylidene difluoride membrane (Perkin-Elmer Life Sciences Inc., Boston, MA, USA). The antibodies used were: p27kip1 antibody (clone 57; BD Bioscience) at 1:2500, phospho-p27 T157 and T198 (R&D Systems, Minneapolis, MN, USA), each at 1:10 000, total AKT (used at 1:2500) or phospho-AKT (S473; 1:2500) from Cell Signaling Technology. Lamin A (1:2500) and a-tubulin (1:2500) antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). GAPDH (1:10 000) antibody from Millipore (Billerica, MA, USA) and b-actin antibody (1:20 000) from Sigma. Horseradish peroxidase-conjugated secondary antibodies were from Santa Cruz. Immune detection was performed by enhanced chemiluminescence (Perkin-Elmer Life Sciences Inc.). Amersham ECL Advance Western Blotting Detection Kit was used for detection of phospho-p27 T157 and T198 (GE Healthcare, Piscataway, NJ, USA). Numerical data were derived by densitometry, using ImageJ 1.42q software (NIH, Bethesda, MD, USA).
Immunofluorescence assays AGS cells were seeded in eight-well chamber slides (Thermo Scientific, Rochester, NY, USA) and co-cultured with H. pylori for 10 h. Epithelial cells were then fixed with 4% paraformaldehyde for 10 min and permeabilized with 0.1% triton X-100 for 15 min. Endogenous p27 was identified by primary mouse anti-p27 antibody (Cat. #18-2370, Invitrogen), with Alexa Fluor 594 rabbit anti-mouse secondary antibody (Invitrogen #A-11062). Nuclei were labeled using Vectashield mounting medium with 4,6-diamidino-2-phenylindole (Vector Laboratories, Burlingame, CA, USA). Confocal images were acquired with a Nikon C1si confocal microscope (Nikon Inc., Mellville, NY, USA) using diode lasers 402 and 561. Serial optical sections were performed with EZ-C1 computer software (Nikon Inc.) and Z-series sections collected at 0.2 mm with a 60 Â PlanApo lens and scan zoom of 2. Images were processed in Elements computer software (Nikon Inc.).
Plasmids and siRNA
A series of plasmids encoding wild-type and mutant p27-YFP fusion proteins were utilized . The p27 mutants included a threonine to alanine substitution at position 157 (p27T157A), an aspartic acid substitution of the same residue (p27T157D), a threonine to alanine substitution at position 198 (p27T198A), an aspartic acid substitution of the same residue (p27T198D) and a double threonine to alanine substitution (p27T157AT198A). YFP-p27 constructs were subcloned into the pCMV-Myc-tag plasmid (Agilent Technologies, Marlborough, MA, USA) using PCR Cloning, In-Fusion Advantage Kits (Clontech, Mountain View, CA, USA). SKP2 (Cat. # AM51331) and AKT (Cat. # 6511) siRNAs were purchased from Ambion (Austin, TX, USA) and Cell Signaling, respectively.
Transient transfection of plasmid and siRNA AGS cells were transiently transfected with p27 plasmids and siRNA using GenJet Plus DNA in vitro Tranfection reagent and GenMute siRNA & DNA Transfection Reagents (both from SignaGen Laboratories, Gaithersburg, MD, USA).
Gastric cancer cases and p27 immunohistochemistry
Human gastric cancer tissue microarrays were constructed with four tumor tissue cores per case from surgically resected gastric cancers (Resnick et al., 2005) . Five histologically normal gastric biopsies and five cases of intestinal metaplasia were also included. Four-micron sections were immunostained using mouse anti-p27 antibody (clone 57, 1:100 dilution, Invitrogen) and the DAB Map Kit on an automated immunohistochemistry platform (Ventana Medical Systems Inc., Tuscon, AZ, USA). The extent (0-100%) and intensity (scale 0-3) of p27 immunostaining was evaluated separately for nucleus and cytoplasm of tumor cells by KS and MBR. Scores from all four cores per case were averaged for overall extent and intensity. Because there is no standard scoring system for p27 immunostaining (Wander et al., 2011) , cytoplasmic p27 was scored as high (intensity scale 41) or low (intensity scale p1), and levels of nuclear p27 were scored as high (X52%) or low (o52%). These cut-offs were based on regression tree analysis, and in accordance with previous studies (Liang et al., 2002) . Patient demographics, tumor histology, stage, adjuvant therapy and recurrence and survival data were ascertained through the Rhode Island Tumor Registry and hospital chart review. This study was approved by the Institutional Review Board of Rhode Island Hospital.
Statistical methods
All cell culture experiments were repeated at least three times and paired t-tests were used to determine statistical significance (GraphPad Prism, Graphpad Software Inc., La Jolla, CA, USA). Regression tree analysis was used to identify subsets and conditions by which p27 expression could be used to predict survival. We estimated the survival distributions using the Kaplan-Meier method and tested for equivalence of distributions using the log rank test. A multivariate Cox proportional hazards regression model was used to examine the association of nuclear and cytoplasmic p27 expression with survival, adjusting for demographic, tumor specific and adjuvant therapy variables, namely age, gender, tumor stage, tumor histological subtype and whether or not the patient had undergone adjuvant chemotherapy or radiation therapy.
